Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect-based evaluation of ozone treatment for removal of micropollutants and their transformation products in waste water.
Dopp E, Pannekens H, Gottschlich A, Schertzinger G, Gehrmann L, Kasper-Sonnenberg M, Richard J, Joswig M, Grummt T, Schmidt TC, Wilhelm M, Tuerk J. Dopp E, et al. Among authors: gottschlich a. J Toxicol Environ Health A. 2021 May 19;84(10):418-439. doi: 10.1080/15287394.2021.1881854. Epub 2021 Feb 24. J Toxicol Environ Health A. 2021. PMID: 33622194
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.
Stock S, Fertig L, Gottschlich A, Dörr J, Märkl F, Majed L, Menkhoff VD, Grünmeier R, Rejeski K, Cordas Dos Santos DM, Theurich S, von Bergwelt-Baildon M, Endres S, Subklewe M, Kobold S. Stock S, et al. Among authors: gottschlich a. Cancer Immunol Immunother. 2024 Apr 17;73(6):100. doi: 10.1007/s00262-024-03688-4. Cancer Immunol Immunother. 2024. PMID: 38630291 Free PMC article.
Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets.
Xhaxho S, Chen-Wichmann L, Kreissig S, Windisch R, Gottschlich A, Nandi S, Schabernack S, Kohler I, Kellner C, Kobold S, Humpe A, Wichmann C. Xhaxho S, et al. Among authors: gottschlich a. Transfus Med Hemother. 2023 Aug 30;51(2):111-118. doi: 10.1159/000532130. eCollection 2024 Apr. Transfus Med Hemother. 2023. PMID: 38584695 Free PMC article.
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology.
Nowotny HF, Marchant Seiter T, Ju J, Gottschlich A, Schneider H, Zopp S, Vogel F, Tschaidse L, Auer MK, Lottspeich C, Kobold S, Rothenfusser S, Beuschlein F, Reincke M, Braun L, Reisch N. Nowotny HF, et al. Among authors: gottschlich a. Front Immunol. 2023 Nov 15;14:1275828. doi: 10.3389/fimmu.2023.1275828. eCollection 2023. Front Immunol. 2023. PMID: 38045693 Free PMC article.
Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study.
Gottschlich A, Gondara L, Smith LW, Anderson JJ, Cook D, Krajden M, Lee M, Martin RE, Melnikow J, Peacock S, Proctor L, Stuart G, Franco EL, van Niekerk D, Ogilvie GS. Gottschlich A, et al. Lancet Reg Health Am. 2023 Sep 29;26:100598. doi: 10.1016/j.lana.2023.100598. eCollection 2023 Oct. Lancet Reg Health Am. 2023. PMID: 37786399 Free PMC article.
Higher perceived stress during the COVID-19 pandemic increased menstrual dysregulation and menopause symptoms.
Garcia de Leon R, Baaske A, Albert AY, Booth A, Racey CS, Gordon S, Smith LW, Gottschlich A, Sadarangani M, Kaida A, Ogilvie GS, Brotto LA, Galea LAM. Garcia de Leon R, et al. Among authors: gottschlich a. Womens Health (Lond). 2023 Jan-Dec;19:17455057231199051. doi: 10.1177/17455057231199051. Womens Health (Lond). 2023. PMID: 37732492 Free PMC article.
Programmable multispecific DNA-origami-based T-cell engagers.
Wagenbauer KF, Pham N, Gottschlich A, Kick B, Kozina V, Frank C, Trninic D, Stömmer P, Grünmeier R, Carlini E, Tsiverioti CA, Kobold S, Funke JJ, Dietz H. Wagenbauer KF, et al. Among authors: gottschlich a. Nat Nanotechnol. 2023 Nov;18(11):1319-1326. doi: 10.1038/s41565-023-01471-7. Epub 2023 Aug 17. Nat Nanotechnol. 2023. PMID: 37591933 Free PMC article.
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma.
Märkl F, Benmebarek MR, Keyl J, Cadilha BL, Geiger M, Karches C, Obeck H, Schwerdtfeger M, Michaelides S, Briukhovetska D, Stock S, Jobst J, Müller PJ, Majed L, Seifert M, Klüver AK, Lorenzini T, Grünmeier R, Thomas M, Gottschlich A, Klaus R, Marr C, von Bergwelt-Baildon M, Rothenfusser S, Levesque MP, Heppt MV, Endres S, Klein C, Kobold S. Märkl F, et al. Among authors: gottschlich a. J Immunother Cancer. 2023 May;11(5):e006436. doi: 10.1136/jitc-2022-006436. J Immunother Cancer. 2023. PMID: 37208128 Free PMC article.
51 results